Biopharma EHS

Categories

general

Archives

2020
February
January

2017
July
May

2016
January

2014
November
October

2013
July
June

2012
July
January

2011
December
May
April
March
February
January

2010
December

May 2011
S M T W T F S
     
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Syndication

In this podcast, Dean M. Calhoun, CIH and Joe Nieusma, Ph.D. of Affygility Solutions discuss Category 4 and Category 5 Potent Compounds - Understanding the Risks.

Items covered include:

  • Review of the last podcast
  • What factors go into determining an active pharmaceutical ingredients as a Category 4 or Category 5 potent compound
  • We provide examples of Category 4 and Category 5 potent compounds
  • Review upcoming events and happenings related to environmental, health and safety in the biotechnology, pharmaceutical, and medical device industry.

If you have any questions please contact Affygility Solutions at 303-884-3028 or visit the Affygility Solutions website.

Direct download: Biopharma_EHS_Podcast_Episode_No._16.mp3
Category:general -- posted at: 11:51am MDT